| A randomized, open-label study of the safety and tolerability of fospropofol for patients requiring intubation and mechanical ventilation in the intensive care unit. | |
| | |
MedLine Citation:
|
PMID: 21596879 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Current drugs for induction and maintenance of sedation in mechanically ventilated patients in the intensive care unit have limitations. Fospropofol, a prodrug of propofol, has not been studied as a sedative in the ICU setting. METHODS: In this randomized, open-label pilot study, patients received 1 of 3 regimens with a goal of maintaining a Ramsay Sedation Score of 2 to 5: (1) fospropofol IV infusion with a bolus and increased infusion rate for agitation events (infusion/bolus); (2) fospropofol IV infusion with an increased infusion rate for agitation events (infusion only); or (3) propofol IV infusion with an increased infusion rate for agitation events. RESULTS: Sixty patients received study drug and were included in the safety and efficacy analyses. Because incidence rates for adverse events were similar between fospropofol groups, and because the study was not powered to determine significant differences between treatment groups for safety variables, adverse events for both fospropofol groups were combined. In the fospropofol groups, 28 out of 38 patients (74%) experienced treatment-emergent adverse events in comparison with 14 out of 22 patients (64%) in the propofol group. The most common treatment-emergent adverse events with fospropofol were procedural pain (21.1%) and nausea (13.2%). Two patients (1 each in the fospropofol infusion/bolus and the propofol groups) experienced hypotension during the study as a potential sedation-related adverse event. Mean plasma formate levels were not significantly different among groups. Patients in all 3 treatment groups maintained Ramsay Sedation Scores of 2 to 5 for >90% of the time they were sedated. CONCLUSION: This pilot study suggests that fospropofol, administered in either an infusion/bolus or infusion-only regimen, is tolerable and effective for short-term induction and maintenance of sedation in mechanically ventilated intensive care unit patients. |
| | |
Authors:
|
Keith A Candiotti; Tong J Gan; Christopher Young; Alex Bekker; S T John Sum-Ping; Richard Kahn; Philip Lebowitz; Jeffrey J Littman |
Related Documents
:
|
22116109 - Interventional stroke therapies in the elderly: are we helping? 17950209 - The natural history of untreated dorsal wrist ganglia and patient reported outcome 6 ye... 22150139 - Correction of myopathic blepharoptosis by check ligament suspension: clinical evaluatio... 21999319 - Evaluation of intraventricular hemorrhage assessment methods for predicting outcome fol... 21757569 - Fondaparinux for isolated superficial-vein thrombosis of the legs: a cost-effectiveness... 21709059 - Mortality and readmission of patients with heart failure, atrial fibrillation, or coron... 14872109 - Montelukast treatment does not affect peripheral blood neutrophil functions in asthma p... 6471219 - Cutaneous ureterostomy as a permanent external urinary diversion in children. 10856859 - Morphologic grading of emphysema is useful in the selection of candidates for unilatera... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. Date: 2011-05-19 |
Journal Detail:
|
Title: Anesthesia and analgesia Volume: 113 ISSN: 1526-7598 ISO Abbreviation: Anesth. Analg. Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-08-24 Completed Date: 2011-10-14 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 1310650 Medline TA: Anesth Analg Country: United States |
Other Details:
|
Languages: eng Pagination: 550-6 Citation Subset: AIM; IM |
Affiliation:
|
Department of Anesthesiology, University of Miami/Jackson Memorial Hospital, R-C370, 1611 NW 12th Avenue, Miami, FL 33101, USA. kcandiotti@miami.edu |
| Data Bank Information | |
Bank Name/Acc. No.:
|
ClinicalTrials.gov/NCT00125398 |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Drug Administration Schedule Female Humans Hypnotics and Sedatives / administration & dosage*, adverse effects Infusions, Intravenous Injections, Intravenous Intensive Care* Intensive Care Units Intubation, Intratracheal* Male Middle Aged Pilot Projects Propofol / administration & dosage, adverse effects, analogs & derivatives* Respiration, Artificial* Time Factors Treatment Outcome United States Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Hypnotics and Sedatives; 2078-54-8/Propofol; LZ257RZP7K/fospropofol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Malignant Disease Within 5 Years After Surgery in Relation to Duration of Sevoflurane Anesthesia and...
Next Document: Isoflurane posttreatment reduces brain injury after an intracerebral hemorrhagic stroke in mice.